群発頭痛症候群の世界市場レポート 2025年

群発頭痛症候群市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は6.7％で、11億1,000万米ドルに成長します。予測期間における成長の背景には、神経疾患の有病率の上昇、新薬開発への投資の増加、ヘルスケア支出の増加、うつ病患者数の増加、医薬品の承認数の増加があります。予測期間における主な動向としては、技術の進歩、遠隔医療、個別化医療、神経調節技術、標的薬物療法などが挙げられます。

神経疾患の有病率の増加は、群発頭痛症候群市場の成長を促進すると予測されます。神経疾患には、脳、脊髄、全身の神経を含む神経系に影響を及ぼすさまざまな状態が含まれます。神経疾患の増加は、糖尿病などの危険因子の有病率の増加、診断能力の向上、他の疾患による神経学的合併症、社会経済的格差などの要因に影響されています。神経疾患の治療は、これらの疾患の一部が頭痛経路と重複していたり、影響を及ぼしていたりするため、群発頭痛症候群の管理に役立ちます。群発頭痛の症状や根本的な要因に対処することで、その頻度、重症度、影響を効果的に軽減することができます。例えば、2022年4月、ベルギーを拠点とする非営利団体であるEuropean Brain Councilは、1,050万人の欧州人が認知症（神経疾患）に罹患していると報告し、この数は2050年までに1,870万人に増加すると予測しています。したがって、神経疾患の有病率の増加が群発頭痛症候群市場を牽引しています。

群発頭痛症候群市場の主要企業は、より効果的な治療オプションを提供するため、植え込み型神経刺激システムなどの先進技術の開発に注力しています。植え込み型神経刺激技術は、神経系の特定部位に電気インパルスを供給するデバイスを外科的に植え込むものです。例えば、2023年8月、オランダに本社を置く医療機器会社Salvia BioElectronics社は、重度の片頭痛や群発頭痛を治療するために設計された紙製の薄型神経刺激装置を発表しました。この革新的な装置には、超薄型のバイオエレクトロニック・フォイルが含まれており、一度埋め込むと患者の頭の形に適応し、標的を絞った電気パルスを供給します。片頭痛や群発性頭痛は、特定の脳領域における感受性の亢進と関連しているため、この装置から供給される電気パルスは、バランスを回復し、頭痛を緩和するのに役立ちます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界群発頭痛症候群 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の群発頭痛症候群市場：成長率分析
• 世界の群発頭痛症候群市場の実績：規模と成長, 2019-2024
• 世界の群発頭痛症候群市場の予測：規模と成長, 2024-2029, 2034F
• 世界群発頭痛症候群総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の群発頭痛症候群市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• エピソード
• 慢性
• 世界の群発頭痛症候群市場薬剤の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• カルシウムチャネル遮断薬
• コルチコステロイド
• スマトリプタン
• 炭酸リチウム
• 麦角
• メラトニン
• 抗てんかん薬
• 局所麻酔薬
• 世界の群発頭痛症候群市場診断別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 神経学的検査
• 磁気共鳴画像法
• コンピュータ断層撮影スキャン
• 世界の群発頭痛症候群市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• オーラル
• トピック
• 静脈内
• その他の投与経路
• 世界の群発頭痛症候群市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 小売薬局
• オンラインストア
• その他の流通チャネル
• 世界の群発頭痛症候群市場、エピソードのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 短時間発作性群発頭痛
• 長期にわたる発作性群発頭痛
• 世界の群発頭痛症候群市場慢性疾患のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 頻繁な発作を伴う慢性群発性頭痛
• まれな発作を伴う慢性群発性頭痛

第7章 地域別・国別分析

• 世界の群発頭痛症候群市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の群発頭痛症候群市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 群発頭痛症候群市場：競合情勢
• 群発頭痛症候群市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
  • Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis
  • Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Viatris Inc.
• Teva Pharmaceutical Industries Ltd.
• Otsuka Pharmaceutical Co. Ltd.
• Hikma Pharmaceuticals
• Amneal Pharmaceuticals
• Grunenthal GmbH
• Mallinckrodt Pharmaceuticals
• Upsher-Smith Laboratories
• Zogenix Inc.
• Neurelis Inc.
• ElectroCore Medical LLC
• Ceruvia Lifesciences
• TrioxBio Inc.
• Winston Pharmaceuticals Inc.
• Zosano Pharma Corporation

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 群発頭痛症候群市場2029：新たな機会を提供する国
• 群発頭痛症候群市場2029：新たな機会を提供するセグメント
• 群発頭痛症候群市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Cluster headache syndrome is a condition marked by severe, recurrent headaches that occur in clusters or episodes. These headaches are typically one-sided and extremely painful, often described as sharp, burning, or piercing sensations. They usually manifest around the eye or temple area and last between 15 minutes and three hours.

The main types of cluster headache syndrome are episodic and chronic. Episodic cluster headache features relatively long, pain-free remissions between headache episodes and is the more common type, affecting about 90% of those with the condition. Various medications used to treat cluster headaches include calcium channel blockers, corticosteroids, sumatriptan, lithium carbonate, ergots, melatonin, anti-seizure drugs, and local anesthetics. Diagnosis may involve neurological examination, magnetic resonance imaging (MRI), and computed tomography (CT) scans. Treatments can be administered orally, topically, intravenously, and through other methods, and are available through channels such as hospital pharmacies, retail pharmacies, online stores, and more.

The cluster headache syndromes market research report is one of a series of new reports from The Business Research Company that provides cluster headache syndromes market statistics, including cluster headache syndromes industry global market size, regional shares, competitors with a cluster headache syndromes market share, detailed cluster headache syndromes market segments, market trends, and opportunities, and any further data you may need to thrive in the cluster headache syndromes industry. This cluster headache syndromes research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The cluster headache syndrome market size has grown strongly in recent years. It will grow from $0.8 billion in 2024 to $0.85 billion in 2025 at a compound annual growth rate (CAGR) of 7.0%. The growth in the historic period can be attributed to a rise in public health initiatives, growth in research and development for headache treatments, increasing awareness of neurological disorders, growth in multinational clinical trials, and a rise in the availability of supportive therapies.

The cluster headache syndrome market size is expected to see strong growth in the next few years. It will grow to $1.11 billion in 2029 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to the rising prevalence of neurological disorders, rising investments in the development of new drugs, increasing healthcare spending, rising number of depression cases, and rising approval of drugs. Major trends in the forecast period include technological advancements, telemedicine, personalized medicine, neuromodulation techniques, and targeted drug therapies.

The increasing prevalence of neurological disorders is anticipated to drive the growth of the cluster headache syndrome market. Neurological disorders encompass a range of conditions affecting the nervous system, including the brain, spinal cord, and nerves throughout the body. The rise in neurological disorders is influenced by factors such as the growing prevalence of risk factors such as diabetes, improved diagnostic capabilities, neurological complications from other conditions, and socioeconomic disparities. Treatments for neurological disorders can help manage cluster headache syndrome, as some of these conditions overlap with or impact headache pathways. Addressing the symptoms and underlying factors of cluster headaches can effectively reduce their frequency, severity, and impact. For instance, in April 2022, the European Brain Council, a Belgium-based non-profit organization, reported that 10.5 million Europeans were affected by dementia (a neurological disorder), with this number expected to rise to 18.7 million by 2050. Therefore, the growing prevalence of neurological disorders is driving the cluster headache syndrome market.

Leading companies in the cluster headache syndrome market are focusing on developing advanced technologies, such as implantable neurostimulation systems, to offer more effective treatment options. Implantable neurostimulation technology involves surgically implanted devices that deliver electrical impulses to specific areas of the nervous system. For example, in August 2023, Salvia BioElectronics, a medical device company based in the Netherlands, introduced a paper-thin neuromodulation device designed to treat severe migraines and cluster headaches. This innovative device includes ultra-thin bioelectronic foils that adapt to the shape of the patient's head once implanted, delivering targeted electrical pulses. Since migraines and cluster headaches are associated with heightened sensitivity in certain brain areas, the electrical pulses provided by the device help restore balance and alleviate the headaches.

In October 2022, Emergex Vaccines Holding Limited, a UK-based biotechnology company, acquired the assets of Zosano Pharma Corporation, including intellectual property, license agreements, and manufacturing equipment, for an undisclosed amount. This acquisition enables Emergex to utilize Zosano's microneedle patch technology and manufacturing capabilities. Zosano Pharma Corporation is a US-based clinical-stage biopharmaceutical company specializing in developing treatments for cluster headache syndrome.

Major companies operating in the cluster headache syndrome market are Pfizer Inc., Bayer AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Viatris Inc., Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Hikma Pharmaceuticals, Amneal Pharmaceuticals, Grunenthal GmbH, Mallinckrodt Pharmaceuticals, Upsher-Smith Laboratories, Zogenix Inc., Neurelis Inc., ElectroCore Medical LLC, Ceruvia Lifesciences, TrioxBio Inc., Winston Pharmaceuticals Inc., Zosano Pharma Corporation, Autonomic Technologies Inc., H. Lundbeck A/S

North America was the largest region in the cluster headache syndrome market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cluster headache syndrome market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cluster headache syndrome market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cluster headache syndrome market consists of revenues earned by entities by providing services such as clinical services, specialized consultations, patient education programs, and support services. and related medical devices, microneedle patch technology, and diagnostic tools. The market value includes the value of related goods sold by the service provider or included within the service offering. The cluster headache syndrome market also includes sales of abortive medication, fast-acting analgesics, calcium channel blockers, corticosteroids, and anticonvulsants. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cluster Headache Syndrome Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cluster headache syndrome market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cluster headache syndrome ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cluster headache syndrome market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Episodic; Chronic
• 2) By Drug Type: Calcium Channel Blockers; Corticosteroids; Sumatriptan; Lithium Carbonate; Ergots; Melatonin; Anti-Seizure; Local Anesthetics
• 3) By Diagnosis: Neurological Examination; Magnetic Resonance Imaging; Computed Tomography Scan
• 4) By Route of Administration: Oral; Topical; Intravenous; Other Routes Of Administration
• 5) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Stores; Other Distribution Channels
• Subsegments:
• 1) By Episodic: Short-Duration Episodic Cluster Headaches; Long-Duration Episodic Cluster Headaches
• 2) By Chronic: Chronic Cluster Headaches With Frequent Attacks; Chronic Cluster Headaches With Rare Attacks
• Companies Mentioned: Pfizer Inc.; Bayer AG; GlaxoSmithKline plc; Takeda Pharmaceutical Company Limited; Eli Lilly and Company
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cluster Headache Syndrome Market Characteristics

3. Cluster Headache Syndrome Market Trends And Strategies

4. Cluster Headache Syndrome Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Cluster Headache Syndrome Growth Analysis And Strategic Analysis Framework

• 5.1. Global Cluster Headache Syndrome PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Cluster Headache Syndrome Market Growth Rate Analysis
• 5.4. Global Cluster Headache Syndrome Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Cluster Headache Syndrome Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Cluster Headache Syndrome Total Addressable Market (TAM)

6. Cluster Headache Syndrome Market Segmentation

• 6.1. Global Cluster Headache Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Episodic
• Chronic
• 6.2. Global Cluster Headache Syndrome Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Calcium Channel Blockers
• Corticosteroids
• Sumatriptan
• Lithium Carbonate
• Ergots
• Melatonin
• Anti-Seizure
• Local Anesthetics
• 6.3. Global Cluster Headache Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Neurological Examination
• Magnetic Resonance Imaging
• Computed Tomography Scan
• 6.4. Global Cluster Headache Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Topical
• Intravenous
• Other Routes Of Administration
• 6.5. Global Cluster Headache Syndrome Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Stores
• Other Distribution Channels
• 6.6. Global Cluster Headache Syndrome Market, Sub-Segmentation Of Episodic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Short-Duration Episodic Cluster Headaches
• Long-Duration Episodic Cluster Headaches
• 6.7. Global Cluster Headache Syndrome Market, Sub-Segmentation Of Chronic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chronic Cluster Headaches With Frequent Attacks
• Chronic Cluster Headaches With Rare Attacks

7. Cluster Headache Syndrome Market Regional And Country Analysis

• 7.1. Global Cluster Headache Syndrome Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Cluster Headache Syndrome Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cluster Headache Syndrome Market

• 8.1. Asia-Pacific Cluster Headache Syndrome Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Cluster Headache Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Cluster Headache Syndrome Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Cluster Headache Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cluster Headache Syndrome Market

• 9.1. China Cluster Headache Syndrome Market Overview
• 9.2. China Cluster Headache Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Cluster Headache Syndrome Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Cluster Headache Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cluster Headache Syndrome Market

• 10.1. India Cluster Headache Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Cluster Headache Syndrome Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Cluster Headache Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cluster Headache Syndrome Market

• 11.1. Japan Cluster Headache Syndrome Market Overview
• 11.2. Japan Cluster Headache Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Cluster Headache Syndrome Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Cluster Headache Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cluster Headache Syndrome Market

• 12.1. Australia Cluster Headache Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Cluster Headache Syndrome Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Cluster Headache Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cluster Headache Syndrome Market

• 13.1. Indonesia Cluster Headache Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Cluster Headache Syndrome Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Cluster Headache Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cluster Headache Syndrome Market

• 14.1. South Korea Cluster Headache Syndrome Market Overview
• 14.2. South Korea Cluster Headache Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Cluster Headache Syndrome Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Cluster Headache Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cluster Headache Syndrome Market

• 15.1. Western Europe Cluster Headache Syndrome Market Overview
• 15.2. Western Europe Cluster Headache Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Cluster Headache Syndrome Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Cluster Headache Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cluster Headache Syndrome Market

• 16.1. UK Cluster Headache Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Cluster Headache Syndrome Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Cluster Headache Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cluster Headache Syndrome Market

• 17.1. Germany Cluster Headache Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Cluster Headache Syndrome Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Cluster Headache Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cluster Headache Syndrome Market

• 18.1. France Cluster Headache Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Cluster Headache Syndrome Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Cluster Headache Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cluster Headache Syndrome Market

• 19.1. Italy Cluster Headache Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Cluster Headache Syndrome Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Cluster Headache Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cluster Headache Syndrome Market

• 20.1. Spain Cluster Headache Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Cluster Headache Syndrome Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Cluster Headache Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cluster Headache Syndrome Market

• 21.1. Eastern Europe Cluster Headache Syndrome Market Overview
• 21.2. Eastern Europe Cluster Headache Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Cluster Headache Syndrome Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Cluster Headache Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cluster Headache Syndrome Market

• 22.1. Russia Cluster Headache Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Cluster Headache Syndrome Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Cluster Headache Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cluster Headache Syndrome Market

• 23.1. North America Cluster Headache Syndrome Market Overview
• 23.2. North America Cluster Headache Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Cluster Headache Syndrome Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Cluster Headache Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cluster Headache Syndrome Market

• 24.1. USA Cluster Headache Syndrome Market Overview
• 24.2. USA Cluster Headache Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Cluster Headache Syndrome Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Cluster Headache Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cluster Headache Syndrome Market

• 25.1. Canada Cluster Headache Syndrome Market Overview
• 25.2. Canada Cluster Headache Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Cluster Headache Syndrome Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Cluster Headache Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cluster Headache Syndrome Market

• 26.1. South America Cluster Headache Syndrome Market Overview
• 26.2. South America Cluster Headache Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Cluster Headache Syndrome Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Cluster Headache Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cluster Headache Syndrome Market

• 27.1. Brazil Cluster Headache Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Cluster Headache Syndrome Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Cluster Headache Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cluster Headache Syndrome Market

• 28.1. Middle East Cluster Headache Syndrome Market Overview
• 28.2. Middle East Cluster Headache Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Cluster Headache Syndrome Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Cluster Headache Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cluster Headache Syndrome Market

• 29.1. Africa Cluster Headache Syndrome Market Overview
• 29.2. Africa Cluster Headache Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Cluster Headache Syndrome Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Cluster Headache Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cluster Headache Syndrome Market Competitive Landscape And Company Profiles

• 30.1. Cluster Headache Syndrome Market Competitive Landscape
• 30.2. Cluster Headache Syndrome Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis

31. Cluster Headache Syndrome Market Other Major And Innovative Companies

• 31.1. Viatris Inc.
• 31.2. Teva Pharmaceutical Industries Ltd.
• 31.3. Otsuka Pharmaceutical Co. Ltd.
• 31.4. Hikma Pharmaceuticals
• 31.5. Amneal Pharmaceuticals
• 31.6. Grunenthal GmbH
• 31.7. Mallinckrodt Pharmaceuticals
• 31.8. Upsher-Smith Laboratories
• 31.9. Zogenix Inc.
• 31.10. Neurelis Inc.
• 31.11. ElectroCore Medical LLC
• 31.12. Ceruvia Lifesciences
• 31.13. TrioxBio Inc.
• 31.14. Winston Pharmaceuticals Inc.
• 31.15. Zosano Pharma Corporation

32. Global Cluster Headache Syndrome Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cluster Headache Syndrome Market

34. Recent Developments In The Cluster Headache Syndrome Market

35. Cluster Headache Syndrome Market High Potential Countries, Segments and Strategies

• 35.1 Cluster Headache Syndrome Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Cluster Headache Syndrome Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Cluster Headache Syndrome Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer